CIBUS BUSINESS MODEL CANVAS TEMPLATE RESEARCH
What is included in the product
Detailed Word Document
Cibus BMC reflects their real-world plans.
Customizable Excel Spreadsheet
Saves hours of formatting and structuring your own business model.
Preview Before You Purchase
Business Model Canvas
What you see here is the complete Cibus Business Model Canvas document. The preview provides a direct look at the final deliverable. Purchasing unlocks the same, fully-editable fileāno hidden content. Get the full document, ready to use, instantly!
Business Model Canvas Template
Cibus: A Business Model Canvas Breakdown
Explore the inner workings of Cibus with its Business Model Canvas. This strategic tool unveils their customer segments, value propositions, and revenue streams. It's a clear, concise, and insightful look at their core business. Perfect for investors, analysts, and strategists.
Partnerships
Seed Companies
Cibus strategically collaborates with seed companies to embed its gene-edited traits into their seed lines. This approach is crucial for market reach, avoiding the need for Cibus to produce seeds directly. In 2024, this model has enabled Cibus to expand its footprint, partnering with over 50 seed companies globally. This has facilitated access to diverse geographical markets and crop types. The strategy aligns with Cibus's goal to maximize the impact of its innovations.
Agricultural Research Institutions
Cibus's success hinges on key partnerships with agricultural research institutions. These collaborations are crucial for accessing cutting-edge agricultural science and technology. For instance, in 2024, agricultural biotechnology generated $35.6 billion in revenue. These partnerships facilitate the development of innovative crop traits and sustainable farming methods, directly impacting productivity and profitability.
Biotechnology Companies
Cibus strategically forms key partnerships with biotechnology companies to enhance its capabilities. These collaborations grant access to advanced technologies and specialized knowledge. For instance, a 2024 partnership involved AI-driven gene discovery, speeding up research. These alliances potentially reduce R&D costs and accelerate product development timelines.
Crop Protection Companies
Cibus strategically partners with crop protection companies, including herbicide manufacturers, to enhance its business model. These collaborations are pivotal in creating and marketing integrated weed management solutions. This approach combines gene-edited traits with specific herbicides, optimizing agricultural practices. Such partnerships are essential for market penetration and product success, especially in a competitive landscape.
- In 2024, the global herbicide market was valued at approximately $25 billion.
- Syngenta, a major crop protection company, reported over $15 billion in sales in 2024.
- Collaboration can reduce R&D costs by up to 30% for both parties.
- Integrated solutions can increase crop yields by 10-15%.
Farming Cooperatives
Cibus can broaden its reach by collaborating with farming cooperatives, ensuring its gene-edited seeds get to more farmers. This strategy supports local agriculture and encourages the use of innovative technologies.
This approach simplifies seed distribution, offering farmers easier access to Cibus' products.
Partnering with cooperatives builds strong relationships within the farming community.
For example, in 2024, agricultural cooperatives in the US handled about 30% of all farm products, showing their significant role in distribution.
- Facilitates seed distribution.
- Supports local farmers.
- Promotes technology adoption.
Cibus's Strategic Alliances: A 2024 Overview
Cibus forges vital alliances across the agricultural sector to amplify its impact and streamline market access. These key partnerships span seed companies, biotech firms, crop protection entities, and farming cooperatives. As of 2024, collaborations have significantly expanded Cibus's footprint, boosting efficiency and innovation.
| Partner Type | Strategic Benefit | 2024 Data Highlights |
|---|---|---|
| Seed Companies | Market reach, distribution | 50+ global partners, access to diverse markets. |
| Research Institutions | R&D, innovation | Biotech revenue $35.6B; accelerate tech access. |
| Biotech Companies | Advanced tech, knowledge | AI-driven gene discovery partnerships, quicker R&D. |
| Crop Protection | Integrated solutions | Herbicide market ~$25B; Syngenta's sales ~$15B. |
| Farming Coops | Distribution, farmer access | US coops handled 30% of farm products in 2024. |
Activities
Research and Development
Cibus heavily invests in research and development to create novel gene-edited traits for crops. Their work includes identifying genes and optimizing editing methods. In 2024, R&D spending rose by 15%, focusing on yield improvements. This investment is critical for their long-term market position.
Gene Editing and Trait Development
Cibus's key activity revolves around gene editing, using RTDSĀ® and Trait Machineā¢ to develop superior crop traits. This is their core competency, crucial for their product offerings. In 2024, the global gene editing market was valued at $7.5 billion, showing significant growth. Developing these traits allows for enhanced crop performance and value. This directly supports Cibus's business model by providing differentiated products.
Collaborating with Seed Companies
Cibus's success hinges on strong partnerships with seed companies. They receive germplasm, conduct gene edits, and return seeds for commercial use. This collaboration is crucial for trait commercialization. Cibus's R&D spending in 2024 reached $45 million. These partnerships are vital for market entry.
Regulatory Approvals and Navigating the Regulatory Landscape
Securing regulatory approvals is a central activity for Cibus, enabling them to bring their gene-edited crops to market. The company actively navigates the complex regulatory landscape across various regions, a process that requires significant resources and expertise. This engagement ensures that Cibus's products meet the necessary standards for commercialization. Regulatory hurdles and timelines can vary substantially by region, impacting the speed to market and overall financial projections.
- In 2024, the average time to receive regulatory approval for new agricultural biotech products in the US was 2-3 years.
- The EU has stricter regulations, with approval processes often taking 3-5 years.
- Cibus needs to comply with the regulations of each region where it aims to sell its products.
- Regulatory compliance costs can represent up to 10-15% of the total R&D budget.
Marketing and Education
Cibus focuses on marketing and education to highlight the advantages of gene editing in agriculture and its specific crop traits. This strategy aims to increase market acceptance among farmers and drive adoption of their products. For example, the global agricultural biotechnology market was valued at $50.6 billion in 2023. It's expected to reach $84.1 billion by 2028.
- Market Growth: The agricultural biotechnology market is experiencing significant expansion.
- Adoption Strategy: Cibus's educational efforts are crucial for farmer acceptance.
- Financial Impact: Increased adoption can lead to higher revenue.
- Industry Data: The market is growing rapidly, reflecting technological advancements.
Cibus: Core Activities and Their Impact
Cibus's core activities are centered on cutting-edge R&D, focusing on creating new crop traits using gene editing. Key operations include RTDSĀ® and Trait Machineā¢ technologies.
Partnerships with seed companies for commercialization are critical. Navigating and securing regulatory approvals is also a major focus.
Lastly, marketing and educating farmers drive product adoption, crucial for financial success.
| Activity | Description | Impact |
|---|---|---|
| R&D | Gene editing of crop traits, focusing on yield improvements. | Differentiated products, long-term market position. |
| Partnerships | Collaboration with seed companies for trait commercialization. | Market entry and wider distribution of traits. |
| Regulatory | Securing approvals across regions for product commercialization. | Allows for market entry and compliance. |
Resources
Proprietary Gene Editing Technology (RTDSĀ®)
Cibus's core revolves around its patented RTDSĀ® gene editing tech. This tech allows precise plant gene modification, essential for their business model. In 2024, the global gene editing market was valued at $7.5 billion. Cibus's RTDSĀ® enhances traits like yield and disease resistance, boosting crop value. Their intellectual property is a key competitive advantage.
Skilled Scientists and Researchers
Cibus heavily relies on skilled scientists and researchers. In 2024, Cibus invested $75 million in R&D, reflecting its commitment to innovation. This team drives trait development and genetic engineering. Their expertise is crucial for creating new, valuable products. The success of Cibus is directly tied to this key resource.
Intellectual Property (Patents and Licenses)
Cibus relies heavily on its intellectual property, particularly patents and licenses, to safeguard its gene editing technologies and developed traits. This protection is crucial, given the company's focus on innovation in agriculture. In 2024, Cibus's patent portfolio likely included dozens of patents, reflecting its investment in R&D. Licensing agreements derived from this IP are key revenue streams, estimated to generate a significant portion of their income, around $50 million.
Germplasm and Plant Materials
Cibus relies on high-quality germplasm, the genetic foundation for its gene editing work. This germplasm, including seeds, is often sourced from partnerships with seed companies. In 2024, the global seed market was valued at approximately $68 billion, reflecting the importance of this resource. Access to diverse germplasm is crucial for Cibus to create enhanced crop varieties.
- Source of the germplasm is important for the company.
- Seed companies are the main providers.
- The market size is significant.
- This is key for innovation.
Laboratory Facilities and Equipment
Cibus relies heavily on its laboratory facilities and equipment for its gene-editing work. These resources are crucial for research, conducting gene editing experiments, and evaluating the resulting plants. The quality and capabilities of these facilities directly influence the pace of innovation and the reliability of its products. In 2023, the global market for laboratory equipment reached $64.3 billion.
- Investment in advanced equipment is a significant capital expenditure.
- Maintenance and operational costs are ongoing expenses.
- Access to cutting-edge technology is vital for competitive advantage.
- Compliance with safety and regulatory standards is essential.
Cibus's Core: Data, Seeds, and Labs
Cibus relies on its data and information systems to manage research data. These systems are critical for analyzing genetic data, tracking experimental results, and intellectual property. They store, organize and interpret research findings. In 2024, the market for bioinformatics platforms reached $3.8 billion, reflecting their importance.
| Key Resources | Description | 2024 Data/Details |
|---|---|---|
| Data & Information Systems | Management of research data and intellectual property. | Bioinformatics market at $3.8B, vital for data analysis. |
| Source of the germplasm | Seed companies are the main providers. | The global seed market was ~$68B in 2024, crucial for innovation. |
| Laboratory Facilities and Equipment | These resources are vital for experiments. | Laboratory equipment market ~$64.3B (2023), driving R&D. |
Value Propositions
Increased Crop Yields
Cibus' gene-edited traits boost crop productivity, offering farmers higher yields. This tackles a major agricultural hurdle, enhancing profitability for customers. For example, in 2024, gene-edited crops saw a 10-15% yield increase in trials. This directly translates to more output and revenue.
Reduced Use of Chemical Inputs
Cibus's value proposition includes reducing chemical inputs in farming. They engineer crops for disease and pest resistance. This reduces the need for pesticides.
For example, in 2024, the use of pesticides dropped by 15% in areas using similar biotech crops. Farmers also benefit from less fertilizer use.
This leads to more sustainable agricultural practices. Reduced chemical use can also lower farming costs. This approach has gained traction.
The global market for sustainable agriculture is growing. It was valued at $35.5 billion in 2024. Cibus's focus aligns with this trend.
Their innovations support both environmental and economic benefits for farmers. This creates a strong market position.
Faster Trait Development
Cibus' RTDSĀ® tech speeds up trait development. This leads to faster access to better crops. Traditional breeding takes years, but gene editing drastically cuts this time. For example, Cibus' canola traits hit the market in just 3 years.
Solutions for Difficult-to-Address Agricultural Challenges
Cibus's value proposition includes offering solutions to tough agricultural issues. Gene editing helps overcome challenges like disease or pest resistance, which traditional methods struggle with. This approach can boost crop yields and reduce the need for pesticides. It's a sustainable way to improve food production.
- Gene-edited crops have the potential to increase yields by 10-20% compared to conventional varieties.
- In 2024, the global market for gene-edited crops is estimated to be worth $6.5 billion.
- Gene editing reduces the need for pesticides, potentially lowering costs by 15-25%.
Sustainability and Environmental Benefits
Cibus' value proposition centers on sustainability, developing traits that cut environmental impact and boost resource efficiency. This resonates with farmers and the agricultural value chain, which are now prioritizing eco-friendly practices. This is supported by a growing market: the global sustainable agriculture market was valued at $22.8 billion in 2023.
- Reduced pesticide use: Cibus' gene editing can lead to crops needing fewer pesticides, lowering environmental harm.
- Water conservation: Drought-resistant traits help conserve water resources.
- Carbon footprint reduction: Sustainable farming practices can lower the carbon footprint.
- Market demand: Consumers increasingly favor sustainably produced goods.
Gene Editing Boosts Yields and Cuts Chemicals!
Cibus offers higher crop yields through gene editing, improving farmer profitability. Gene-edited crops showed a 10-15% yield increase in 2024 trials. Their tech reduces chemical use. For instance, pesticide use dropped by 15% in areas with biotech crops. Cibus enables faster trait development using RTDSĀ® tech. For example, canola traits launched in 3 years.
| Aspect | Benefit | Data (2024) |
|---|---|---|
| Yield Improvement | Higher crop output | 10-15% yield increase |
| Chemical Reduction | Lower input costs, environmental impact | Pesticide use down 15% |
| Trait Development | Faster market access | Canola traits in 3 years |
Product Information
Product Information
Shipping & Returns
Shipping & Returns
Description
What is included in the product
Detailed Word Document
Cibus BMC reflects their real-world plans.
Customizable Excel Spreadsheet
Saves hours of formatting and structuring your own business model.
Preview Before You Purchase
Business Model Canvas
What you see here is the complete Cibus Business Model Canvas document. The preview provides a direct look at the final deliverable. Purchasing unlocks the same, fully-editable fileāno hidden content. Get the full document, ready to use, instantly!
Business Model Canvas Template
Cibus: A Business Model Canvas Breakdown
Explore the inner workings of Cibus with its Business Model Canvas. This strategic tool unveils their customer segments, value propositions, and revenue streams. It's a clear, concise, and insightful look at their core business. Perfect for investors, analysts, and strategists.
Partnerships
Seed Companies
Cibus strategically collaborates with seed companies to embed its gene-edited traits into their seed lines. This approach is crucial for market reach, avoiding the need for Cibus to produce seeds directly. In 2024, this model has enabled Cibus to expand its footprint, partnering with over 50 seed companies globally. This has facilitated access to diverse geographical markets and crop types. The strategy aligns with Cibus's goal to maximize the impact of its innovations.
Agricultural Research Institutions
Cibus's success hinges on key partnerships with agricultural research institutions. These collaborations are crucial for accessing cutting-edge agricultural science and technology. For instance, in 2024, agricultural biotechnology generated $35.6 billion in revenue. These partnerships facilitate the development of innovative crop traits and sustainable farming methods, directly impacting productivity and profitability.
Biotechnology Companies
Cibus strategically forms key partnerships with biotechnology companies to enhance its capabilities. These collaborations grant access to advanced technologies and specialized knowledge. For instance, a 2024 partnership involved AI-driven gene discovery, speeding up research. These alliances potentially reduce R&D costs and accelerate product development timelines.
Crop Protection Companies
Cibus strategically partners with crop protection companies, including herbicide manufacturers, to enhance its business model. These collaborations are pivotal in creating and marketing integrated weed management solutions. This approach combines gene-edited traits with specific herbicides, optimizing agricultural practices. Such partnerships are essential for market penetration and product success, especially in a competitive landscape.
- In 2024, the global herbicide market was valued at approximately $25 billion.
- Syngenta, a major crop protection company, reported over $15 billion in sales in 2024.
- Collaboration can reduce R&D costs by up to 30% for both parties.
- Integrated solutions can increase crop yields by 10-15%.
Farming Cooperatives
Cibus can broaden its reach by collaborating with farming cooperatives, ensuring its gene-edited seeds get to more farmers. This strategy supports local agriculture and encourages the use of innovative technologies.
This approach simplifies seed distribution, offering farmers easier access to Cibus' products.
Partnering with cooperatives builds strong relationships within the farming community.
For example, in 2024, agricultural cooperatives in the US handled about 30% of all farm products, showing their significant role in distribution.
- Facilitates seed distribution.
- Supports local farmers.
- Promotes technology adoption.
Cibus's Strategic Alliances: A 2024 Overview
Cibus forges vital alliances across the agricultural sector to amplify its impact and streamline market access. These key partnerships span seed companies, biotech firms, crop protection entities, and farming cooperatives. As of 2024, collaborations have significantly expanded Cibus's footprint, boosting efficiency and innovation.
| Partner Type | Strategic Benefit | 2024 Data Highlights |
|---|---|---|
| Seed Companies | Market reach, distribution | 50+ global partners, access to diverse markets. |
| Research Institutions | R&D, innovation | Biotech revenue $35.6B; accelerate tech access. |
| Biotech Companies | Advanced tech, knowledge | AI-driven gene discovery partnerships, quicker R&D. |
| Crop Protection | Integrated solutions | Herbicide market ~$25B; Syngenta's sales ~$15B. |
| Farming Coops | Distribution, farmer access | US coops handled 30% of farm products in 2024. |
Activities
Research and Development
Cibus heavily invests in research and development to create novel gene-edited traits for crops. Their work includes identifying genes and optimizing editing methods. In 2024, R&D spending rose by 15%, focusing on yield improvements. This investment is critical for their long-term market position.
Gene Editing and Trait Development
Cibus's key activity revolves around gene editing, using RTDSĀ® and Trait Machineā¢ to develop superior crop traits. This is their core competency, crucial for their product offerings. In 2024, the global gene editing market was valued at $7.5 billion, showing significant growth. Developing these traits allows for enhanced crop performance and value. This directly supports Cibus's business model by providing differentiated products.
Collaborating with Seed Companies
Cibus's success hinges on strong partnerships with seed companies. They receive germplasm, conduct gene edits, and return seeds for commercial use. This collaboration is crucial for trait commercialization. Cibus's R&D spending in 2024 reached $45 million. These partnerships are vital for market entry.
Regulatory Approvals and Navigating the Regulatory Landscape
Securing regulatory approvals is a central activity for Cibus, enabling them to bring their gene-edited crops to market. The company actively navigates the complex regulatory landscape across various regions, a process that requires significant resources and expertise. This engagement ensures that Cibus's products meet the necessary standards for commercialization. Regulatory hurdles and timelines can vary substantially by region, impacting the speed to market and overall financial projections.
- In 2024, the average time to receive regulatory approval for new agricultural biotech products in the US was 2-3 years.
- The EU has stricter regulations, with approval processes often taking 3-5 years.
- Cibus needs to comply with the regulations of each region where it aims to sell its products.
- Regulatory compliance costs can represent up to 10-15% of the total R&D budget.
Marketing and Education
Cibus focuses on marketing and education to highlight the advantages of gene editing in agriculture and its specific crop traits. This strategy aims to increase market acceptance among farmers and drive adoption of their products. For example, the global agricultural biotechnology market was valued at $50.6 billion in 2023. It's expected to reach $84.1 billion by 2028.
- Market Growth: The agricultural biotechnology market is experiencing significant expansion.
- Adoption Strategy: Cibus's educational efforts are crucial for farmer acceptance.
- Financial Impact: Increased adoption can lead to higher revenue.
- Industry Data: The market is growing rapidly, reflecting technological advancements.
Cibus: Core Activities and Their Impact
Cibus's core activities are centered on cutting-edge R&D, focusing on creating new crop traits using gene editing. Key operations include RTDSĀ® and Trait Machineā¢ technologies.
Partnerships with seed companies for commercialization are critical. Navigating and securing regulatory approvals is also a major focus.
Lastly, marketing and educating farmers drive product adoption, crucial for financial success.
| Activity | Description | Impact |
|---|---|---|
| R&D | Gene editing of crop traits, focusing on yield improvements. | Differentiated products, long-term market position. |
| Partnerships | Collaboration with seed companies for trait commercialization. | Market entry and wider distribution of traits. |
| Regulatory | Securing approvals across regions for product commercialization. | Allows for market entry and compliance. |
Resources
Proprietary Gene Editing Technology (RTDSĀ®)
Cibus's core revolves around its patented RTDSĀ® gene editing tech. This tech allows precise plant gene modification, essential for their business model. In 2024, the global gene editing market was valued at $7.5 billion. Cibus's RTDSĀ® enhances traits like yield and disease resistance, boosting crop value. Their intellectual property is a key competitive advantage.
Skilled Scientists and Researchers
Cibus heavily relies on skilled scientists and researchers. In 2024, Cibus invested $75 million in R&D, reflecting its commitment to innovation. This team drives trait development and genetic engineering. Their expertise is crucial for creating new, valuable products. The success of Cibus is directly tied to this key resource.
Intellectual Property (Patents and Licenses)
Cibus relies heavily on its intellectual property, particularly patents and licenses, to safeguard its gene editing technologies and developed traits. This protection is crucial, given the company's focus on innovation in agriculture. In 2024, Cibus's patent portfolio likely included dozens of patents, reflecting its investment in R&D. Licensing agreements derived from this IP are key revenue streams, estimated to generate a significant portion of their income, around $50 million.
Germplasm and Plant Materials
Cibus relies on high-quality germplasm, the genetic foundation for its gene editing work. This germplasm, including seeds, is often sourced from partnerships with seed companies. In 2024, the global seed market was valued at approximately $68 billion, reflecting the importance of this resource. Access to diverse germplasm is crucial for Cibus to create enhanced crop varieties.
- Source of the germplasm is important for the company.
- Seed companies are the main providers.
- The market size is significant.
- This is key for innovation.
Laboratory Facilities and Equipment
Cibus relies heavily on its laboratory facilities and equipment for its gene-editing work. These resources are crucial for research, conducting gene editing experiments, and evaluating the resulting plants. The quality and capabilities of these facilities directly influence the pace of innovation and the reliability of its products. In 2023, the global market for laboratory equipment reached $64.3 billion.
- Investment in advanced equipment is a significant capital expenditure.
- Maintenance and operational costs are ongoing expenses.
- Access to cutting-edge technology is vital for competitive advantage.
- Compliance with safety and regulatory standards is essential.
Cibus's Core: Data, Seeds, and Labs
Cibus relies on its data and information systems to manage research data. These systems are critical for analyzing genetic data, tracking experimental results, and intellectual property. They store, organize and interpret research findings. In 2024, the market for bioinformatics platforms reached $3.8 billion, reflecting their importance.
| Key Resources | Description | 2024 Data/Details |
|---|---|---|
| Data & Information Systems | Management of research data and intellectual property. | Bioinformatics market at $3.8B, vital for data analysis. |
| Source of the germplasm | Seed companies are the main providers. | The global seed market was ~$68B in 2024, crucial for innovation. |
| Laboratory Facilities and Equipment | These resources are vital for experiments. | Laboratory equipment market ~$64.3B (2023), driving R&D. |
Value Propositions
Increased Crop Yields
Cibus' gene-edited traits boost crop productivity, offering farmers higher yields. This tackles a major agricultural hurdle, enhancing profitability for customers. For example, in 2024, gene-edited crops saw a 10-15% yield increase in trials. This directly translates to more output and revenue.
Reduced Use of Chemical Inputs
Cibus's value proposition includes reducing chemical inputs in farming. They engineer crops for disease and pest resistance. This reduces the need for pesticides.
For example, in 2024, the use of pesticides dropped by 15% in areas using similar biotech crops. Farmers also benefit from less fertilizer use.
This leads to more sustainable agricultural practices. Reduced chemical use can also lower farming costs. This approach has gained traction.
The global market for sustainable agriculture is growing. It was valued at $35.5 billion in 2024. Cibus's focus aligns with this trend.
Their innovations support both environmental and economic benefits for farmers. This creates a strong market position.
Faster Trait Development
Cibus' RTDSĀ® tech speeds up trait development. This leads to faster access to better crops. Traditional breeding takes years, but gene editing drastically cuts this time. For example, Cibus' canola traits hit the market in just 3 years.
Solutions for Difficult-to-Address Agricultural Challenges
Cibus's value proposition includes offering solutions to tough agricultural issues. Gene editing helps overcome challenges like disease or pest resistance, which traditional methods struggle with. This approach can boost crop yields and reduce the need for pesticides. It's a sustainable way to improve food production.
- Gene-edited crops have the potential to increase yields by 10-20% compared to conventional varieties.
- In 2024, the global market for gene-edited crops is estimated to be worth $6.5 billion.
- Gene editing reduces the need for pesticides, potentially lowering costs by 15-25%.
Sustainability and Environmental Benefits
Cibus' value proposition centers on sustainability, developing traits that cut environmental impact and boost resource efficiency. This resonates with farmers and the agricultural value chain, which are now prioritizing eco-friendly practices. This is supported by a growing market: the global sustainable agriculture market was valued at $22.8 billion in 2023.
- Reduced pesticide use: Cibus' gene editing can lead to crops needing fewer pesticides, lowering environmental harm.
- Water conservation: Drought-resistant traits help conserve water resources.
- Carbon footprint reduction: Sustainable farming practices can lower the carbon footprint.
- Market demand: Consumers increasingly favor sustainably produced goods.
Gene Editing Boosts Yields and Cuts Chemicals!
Cibus offers higher crop yields through gene editing, improving farmer profitability. Gene-edited crops showed a 10-15% yield increase in 2024 trials. Their tech reduces chemical use. For instance, pesticide use dropped by 15% in areas with biotech crops. Cibus enables faster trait development using RTDSĀ® tech. For example, canola traits launched in 3 years.
| Aspect | Benefit | Data (2024) |
|---|---|---|
| Yield Improvement | Higher crop output | 10-15% yield increase |
| Chemical Reduction | Lower input costs, environmental impact | Pesticide use down 15% |
| Trait Development | Faster market access | Canola traits in 3 years |
